Related by context. All words. (Click for frequent words.) 85 Genitourinary Cancers Symposium 80 Prostate Cancer Symposium 80 ASH Annual Meeting 79 nd Annual Meeting 78 ASCO Genitourinary Cancers Symposium 77 ASCO GI 77 AHA Scientific Sessions 76 ASCO Annual Meeting 75 #nd Annual Meeting 75 Hematology ASH Annual Meeting 75 Breast Cancer Symposium 75 AUA Annual Meeting 75 AACR #nd Annual Meeting 74 AACR #st Annual Meeting 74 Cancers Symposium 74 Hematology Annual Meeting 74 Clinical Oncology Annual Meeting 74 AACR San Antonio 74 Annual Scientific Sessions 73 Digestive Diseases Week 73 Digestive Disease Week DDW 73 AACR NCI EORTC 73 ADA Scientific Sessions 72 Digestive Disease Week 72 SABCS 71 CTRC AACR San Antonio 71 Society CTOS 71 Connective Tissue Oncology 71 Therapeutics TCT scientific 70 Symposium SABCS 70 AACR Meeting 70 ICAAC IDSA 70 ICAAC 69 Opportunistic Infections CROI 69 Transcatheter Cardiovascular Therapeutics TCT 69 Breast Cancer Symposium SABCS 69 Endocrine Society Annual Meeting 69 Clinical Oncology ASCO Annual 69 #th Annual Interscience 69 Endocrine Society #nd 69 Chicago Multidisciplinary Symposium 69 Rheumatology ACR Annual 69 Clinical Virology Symposium 69 Molecular Targets 68 EORTC NCI AACR 68 ISPOR 68 International Myeloma Workshop 68 Annual Transcatheter Cardiovascular 68 BIOCOM Investor Conference 68 CROI 68 Hematology ASH 68 Vascular Annual Meeting 68 Late Breaker 68 AASLD 68 Biological Therapy 68 Endocrine Society ENDO 68 Hematology Meeting 68 Scientific Session 68 Cancer iSBTc 68 ASGT 68 ASCO Breast Cancer 68 Therapeutics TCT 68 EORTC NCI AACR Symposium 67 ECTRIMS 67 #nd EORTC NCI 67 UEGW 67 ASCO GU 67 AAAAI Annual Meeting 67 #st Annual Meeting 67 st Annual Meeting 67 ERA EDTA 67 ECCMID 67 ASTRO Annual Meeting 67 EORTC NCI 67 Cardiology Scientific Sessions 67 Endocrine Society #st 67 ACR ARHP Annual 67 #rd Annual CTRC 66 Arteriosclerosis Thrombosis 66 annual Transcatheter Cardiovascular 66 Malignant Lymphoma 66 Canaccord Adams Hepatitis C 66 Transcatheter Cardiovascular Therapeutics 66 ACR ARHP 66 Abstract Number 66 ASCO Gastrointestinal Cancers Symposium 66 AACR IASLC Joint 66 Related Disorders ICAD 66 AACR Annual Meeting 66 AASLD Meeting 66 ARVO 65 Poster Discussion 65 Alzheimer Disease ICAD 65 Rheumatology Annual 65 AAN Annual Meeting 65 Pediatric Academic Societies PAS 65 Scientific Sessions 65 Advanced Neuroendocrine Tumors 65 Cardiovascular Disease Epidemiology 65 abstr 65 AAO HNSF Annual Meeting 65 ARVO Annual Meeting 65 Spine Arthroplasty Society 65 Gastroenterology ACG Annual 65 SAEM Annual Meeting 65 League Against Rheumatism 65 Nephrology Renal Week 65 Vascular Biology ATVB 65 Gastrointestinal Cancer 64 Clinical Oncology ASCO Gastrointestinal 64 CLEO QELS 64 th Interscience Conference 64 Annual ICAAC 64 VEITHsymposium 64 ECCO ESMO 64 America HFSA 64 BIO InvestorForum 64 Clinical Oncology Gastrointestinal Cancers 64 Poster Presentation 64 Chemotherapy ICAAC 64 ORAL Sync 64 Hematology ASH Meeting 64 AACR Frontiers 64 Molecular Medicine Tri 64 Randomized Phase 63 Neurology Annual Meeting 63 NSTI Nanotech 63 Lysosomal Disease Network 63 Oncology ASTRO 63 Pediatric Academic Societies 63 ongoing Phase 1b 63 GASTRO 63 EuroPCR 63 Midyear Clinical Meeting 63 ASMS Conference 63 Endovascular Therapy ISET 63 Oral Presentation 63 Cardiostim 63 Immunology Annual Meeting 63 #th Interscience Conference 63 Neurology AAN 63 Clinical Trials Update 63 Clinical Oncology ASCO 63 J Natl Cancer Inst 63 Oral Presentations 63 randomized controlled Phase 63 Therapeutic Radiology 63 Breaking Clinical Trials 62 Am J Epidemiol 62 INSPIRE Trial Phase III 62 Medical Oncology ESMO 62 AABB Annual Meeting 62 DDW ® 62 EULAR Annual 62 Ophthalmology ARVO 62 Gynecologic Cancer Society 62 Antimicrobial Agents 62 entitled Synergistic 62 Experimental Biology EB 62 Opportunistic Infections 62 USpella 62 Combination REOLYSIN R 62 ® DDW 62 AAPS Annual Meeting 62 European CanCer Organisation ECCO 62 TG MV 62 AACR symposium 62 PROSTVAC TM 62 registrational Phase 62 Environ Health Perspect 62 Oral Fingolimod 62 assessing T DM1 62 HFSA Annual 62 Gaylord Palms Hotel 62 Targeted Anticancer Therapies 62 Preclinical Study 62 Cystic Fibrosis Conference NACFC 62 Pediatric Academic Society 62 Neuro Oncology SNO 62 ASCO abstract 62 Recurrent Chest Wall 62 Keystone Symposia 61 ABRF 61 Poster Session 61 Cardiovascular Therapeutics 61 NCCTG N# 61 J Clin Oncol 61 GTCbio 61 Cambridge Healthtech Institute 61 ASBMR 61 Selective Cardiac Myosin 61 Molecular Origins 61 Cell Biology ASCB 61 Initiated Phase 61 Haemostasis ISTH 61 RECORD1 61 Fifth Decennial International 61 ESTRO 61 Clinical Trial Results 61 ESMO 61 Hsp# Inhibitor 61 non nucleoside inhibitor 61 SPIE Photonics West 61 Clinical Oncologists 61 Hedgehog Pathway Inhibitor 61 novel VDA molecule 61 ECNP 61 Endovascular Therapy 61 Drugs Affecting Lipid 61 BRIM3 61 Systemic Sclerosis 61 Retrovirus Conference 61 EFNS 61 Clinical Antipsychotic Trials 61 CRLX# 61 Radiation Oncology ASTRO 61 Oligonucleotide Therapeutics Society 60 EASL 60 AACR EORTC NCI 60 Phase 1b trial 60 Proc Am Soc 60 Atrial Fibrillation Symposium 60 Gynecologic Investigation 60 Phase III ALLEGRO 60 & Immunology AAAAI 60 NASDAQ CYTK announced 60 Eur Respir J 60 Scientific Meeting 60 Pharmaceutical Scientists AAPS 60 Postgraduate Course 60 pertuzumab 60 Arch Neurol 60 lexidronam injection 60 American Roentgen Ray 60 Metastatic Melanoma 60 liposome injection 60 Randomized Phase III 60 Suppl. 60 Heart Failure Society 60 SCAI Annual 60 Selective Cardiac Myosin Activator 60 Hematological Malignancies 60 PreCISe 60 American Psychosomatic Society 60 Retroviruses 60 Tanespimycin 60 transthyretin TTR mediated amyloidosis 60 HCV SPRINT 60 II Clinical Trial 60 Gene Therapy ASGT 60 Arch Intern Med 60 & OTO EXPO 60 Annual AIFA 60 multicenter Phase 60 Neoplasia 60 Ophthalmology ARVO Annual Meeting 60 Canaccord Genuity Musculoskeletal 60 FOLOTYN ® 60 VoiceCon Spring 60 Thermo Scientific booth 60 FASEB J. 60 EASD 60 AGBT 60 Refractory Angina 60 KRN# 60 Clinical Dermatology 60 SUCCEED trial 60 Antiviral Research 60 Phase Ib study 60 Ann Intern Med 60 Phase 1b clinical trials 60 Phase Ib clinical 60 Phase 2b Clinical Trial 60 ACC.# 60 LabAutomation 60 CTRC AACR 60 Glucosamine Chondroitin Arthritis 60 Nordic ACTI 60 phase 2a 60 Inflammatory Bowel Diseases 60 ENDEAVOR III 60 substudy 60 HDL Mimetic Peptide 60 EMBO J. 60 Phase III ADT 59 Global Healthcare Unplugged 59 ENDO 59 AAAS Annual Meeting 59 Liver Meeting 59 CALGB 59 International Papillomavirus 59 LD Micro 59 Clin Chem 59 TASKi2 59 ABCSG 59 BRIM2 59 BCIRG 59 virus HCV protease inhibitor 59 Intervention Effectiveness 59 PDX pralatrexate 59 Therapeutic Radiation 59 Phase 2a clinical 59 dose escalation clinical 59 PROVENGE sipuleucel T 59 Neck Surgery Foundation 59 sorafenib tablets 59 HORIZONS AMI 59 BiTE R 59 EORTC 59 ISPE Annual Meeting 59 Research IADR 59 histone deacetylase HDAC inhibitor 59 PROSTASCINT R 59 PROactive Study 59 Pooled Analysis 59 Double Blind Placebo 59 RTECC 59 Preclinical Data 59 ASM Biodefense 59 J Clin Endocrinol Metab 59 Anticancer Drugs 59 evaluating tivozanib 59 Nat Genet 59 Ann Rheum Dis 59 CTAP# Capsules 59 Phase #b/#a clinical 59 PITTCON 59 Prostate AdenoCarcinoma Treatment 59 PERSEUS 59 Cancer Therapeutic 59 pan HDAC inhibitor 59 ANN INTERN MED 59 metastatic castration resistant 59 Printable slides 59 EUROGIN 59 AAICAD 59 AIR2 Trial 59 GTCbio 3rd 59 phase IIa clinical 59 Poster Presentations 59 ExTRACT TIMI 59 C# BioVentures Conference 59 Phase #/#a trial 59 Interventions SCAI 59 Anesthesiologists Annual Meeting 59 Gastroenterology ACG 59 HCV RESPOND 2 59 fosbretabulin 59 International Microwave Symposium 59 Drug Formulation 59 Canaccord Genuity Healthy Living 59 Kidney Int 59 Canaccord Adams Musculoskeletal 59 #:#-# [033] 59 phase IIb study 59 PERSEUS clinical program 59 Minimally Invasive Gynecology 59 ORMD 59 Am J Pathol 59 Scientific Poster Session 59 Aflibercept 59 Ann Oncol 59 Phase Ib II 59 Venereology EADV 59 J Am Coll 58 oral FTY# 58 MT# MEDI 58 Relapsing Multiple Sclerosis 58 Biologic Therapy 58 Canaccord Genuity Growth 58 Liver EASL 58 CLARITY TIMI 58 Neuropsychopharmacology 58 Room #AB [002] 58 number NCT# ClinicalTrials.gov 58 NASDAQ SLXP today 58 Targeted Therapies 58 perifosine KRX 58 ASCO 58 Talabostat 58 Inc. Nasdaq AMLN 58 Abstract # 58 Phase III AFFIRM 58 Association EHA 58 International Neuropsychological Society 58 #:#-# [031] 58 Rheumatology Annual Meeting 58 Addex Pharmaceuticals SIX ADXN 58 Phase Ib Clinical Trial 58 Solid Tumors 58 MEND CABG 58 Cardiovascular Interventions 58 Therapeutic Targets 58 AAG geldanamycin analog 58 Nat Med 58 EXPAREL ™ 58 journal Antimicrobial Agents 58 Mass Spectrometry ASMS 58 San Antonio Breast Cancer 58 Personalized Immunotherapy 58 Trodusquemine MSI 58 HCV polymerase inhibitors 58 verteporfin 58 Podium Presentation 58 Infectious Diseases ECCMID 58 Int J Epidemiol 58 #-# Full Text 58 ThermoDox ® clinical 58 Br J Cancer 58 ENDEAVOR IV 58 Antiviral Therapy 58 teriflunomide 58 Cachexia 58 Brentuximab Vedotin SGN 58 Kinase Inhibitor 58 Hormone Refractory Prostate Cancer 58 Electro Optics CLEO 58 Randomized Double blind 58 SCCHN 58 Cardiovascular Renal Physiology 58 multicenter Phase II 58 ganetespib 58 LIGHTFAIR INTERNATIONAL 58 Anesth Analg 58 Glufosfamide 58 Nephrol Dial Transplant 58 ThinkEquity Partners Growth 58 HDL Selective Delipidation 58 Chronic Lymphocytic Leukemia 58 Biotech Showcase 58 IEEE MTT S 58 CALGB # [002] 58 Completes Patient Enrollment 58 ASCO Prostate Cancer 58 Tezampanel 58 antibody blinatumomab MT#/MEDI-# 58 Initiate Phase 58 resistant hormone refractory 58 Annual Interscience Conference 58 Br J Haematol 58 TXPO 58 Androxal TM 58 Obes Res 58 Cardiol 58 mitogen activated ERK kinase 58 SoftScan R 58 Cardiology ESC Congress 58 hormone refractory metastatic prostate 58 prostate cancer mCRPC 58 Vitro Activity 58 Dendritic Cells 58 enzastaurin 58 Fuel Cell Seminar 58 LUX Lung 58 Human Genetics ASHG 58 Active Biotech NASDAQ OMX 58 J.P. Morgan Healthcare 58 Safinamide 58 EFORT Congress 58 initiated Phase Ib 58 evaluating REVLIMID 58 Photovoltaics Summit 58 Carfilzomib 58 depsipeptide 58 J Clin Invest 58 www.asco.org 58 Belimumab 58 American Urological Association 58 preclinical efficacy 58 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 58 Antibody Therapeutics 57 IL# PE#QQR 57 Arch Surg 57 Institutional Investor Forum 57 Hematology 57 Traficet EN 57 Sipuleucel T 57 YONDELIS 57 PNP inhibitor 57 Phase 2a Study 57 Ocular Pharmacology 57 Breast Cancer Assay 57 www.nejm.org 57 BioProcess International 57 Vaccine Immunology 57 Liver Diseases AASLD 57 Genome Biology 57 Clinical Oncology JCO 57 Deforolimus 57 DAS# Fludase ® 57 Needham Biotechnology 57 essential thrombocythemia ET 57 GVAX ® 57 Urology EAU 57 ERA D2C Convention 57 Prospective Multicenter 57 brivanib 57 ELACYT 57 Malignant Mesothelioma 57 Varespladib 57 Ambrisentan 57 preclinical pharmacokinetic 57 selective androgen receptor modulator 57 acute PAO 57 Kamada AAT 57 trastuzumab DM1 T DM1 57 EVEREST II 57 Tumor Microenvironment 57 ThinkEquity Growth 57 Nexavar sorafenib 57 Sangamo BioSciences Announces 57 Stem Cell Research ISSCR 57 ACUITY trial 57 CAMMS# 57 SA FC# 57 EULAR 57 Controlled Release 57 Folfox 57 Female Urology 57 See CLINICAL PHARMACOLOGY 57 Therapeutics Roundtable 57 alvespimycin 57 R roscovitine 57 HDAC Inhibitor 57 AAEP Convention 57 phase III isavuconazole 57 journal Arteriosclerosis Thrombosis 57 Neurological Surgeons Annual Meeting 57 Oncology ESTRO 57 Keynote Lineup 57 ENMD # 57 metastatic hormone refractory 57 Molecular Markers 57 comparing alemtuzumab 57 IASLC 57 interferon gamma 1b 57 ToGA 57 AHIMA Convention 57 Inc. Nasdaq OPTR 57 Randomized Phase II 57 PROTECT AF 57 SAWC WHS 57 #:#-# [023] 57 Ocular Diseases 57 Long Awaited Reality 57 huC# DM4 57 REG2 57 Solorel TM 57 Diabetologia 57 Zenvia Phase III 57 Lancet Oncol 57 SYN# 57 Centers NCBC 57 DigitalFocus 57 J Urol 57 Lung Cancer WCLC 57 Phase 2a trial 57 vascular disrupting agent 57 Prolongs Survival 57 Microbiology ASM 57 oral proteasome inhibitor 57 small molecule Hedgehog 57 Geochimica et Cosmochimica Acta 57 Antithrombotic 57 SCTE Cable Tec EXPO 57 Applied Spectroscopy 57 PANVAC VF 57 Presents Preclinical Data 57 Novel Therapeutics 57 Phase 2b Trial 57 Natalizumab 57 Gynecological Cancer 57 Acute Heart Failure 57 Macula Society 57 Thoracic Oncology 57 HORIZONS AMI trial 57 Inflammatory Arthritis 57 INCB# [001] 57 Crit Care Med 57 DermTech International 57 AIIM Exposition 57 EADV 57 SPIRIT IV 57 delafloxacin 57 BIO VentureForum East 57 Equine Practitioners Convention 57 SID Display Week 57 Pirfenidone 57 Oncologic 57 American Thoracic Society 57 Diabet Med 57 huN# DM1 57 selective kinase inhibitor 57 J Rheumatol 57 FOLFOX6 chemotherapy regimen 57 EchoCRT 57 phase Ib 57 Breaking Clinical Trial 57 TRO# 57 Aggressive Reduction 57 Therapeutic Approaches 57 Tyrosine Kinase Inhibitor 57 Retina Specialists 57 sipuleucel T 57 CCX# 57 Phase III ThermoDox 57 viral kinetic 57 Phase III VISTA 57 Microalbuminuria 57 PEG SN# 57 PRNewswire FirstCall Amylin Pharmaceuticals 57 Elagolix 57 HIMSS# Interoperability Showcase 56 AEG# 56 Aplidin R 56 Cloretazine ® 56 International OARSI 56 Proc Natl Acad Sci 56 HCV Protease Inhibitor 56 JAK2 Inhibitor 56 Anesthesiologists ASA Annual Meeting 56 NO# [002] 56 Doxil ® 56 telomerase therapeutic 56 pralatrexate injection folate analogue 56 investigational immunotherapy 56 Gynecol Oncol 56 Zarnestra 56 HCV NS5B polymerase 56 randomized multicenter trial 56 Antiviral Activity 56 DoDIIS Worldwide Conference 56 Thomas Weisel Partners Tech# 56 IPAA Small Cap 56 Midyear Meeting 56 RADIANT 56 CYT# potent vascular disrupting 56 ADVANCE PD 56 ICR XChange Investor 56 midstage clinical 56 recurrent glioma 56 Storer Auditorium 56 Phacilitate Vaccine Forum 56 Heart Failure Therapies 56 Hypertension ASH 56 HQK 56 radezolid 56 Endocrinol 56 RANK Ligand inhibitor 56 Omacetaxine 56 Tesetaxel 56 Unither 56 resolvin 56 CIMZIA TM certolizumab pegol 56 Acute Myocardial Infarction 56 Physiology Endocrinology 56 FOOD EXPO 56 Respiratory Viral Infections 56 Interventional Radiology SIR 56 EGS# 56 EOquin TM 56 evaluating mipomersen 56 Hepatocellular Carcinoma 56 OvaRex ® MAb 56 Am J Geriatr 56 rALLy clinical trial 56 Val HeFT 56 Trodusquemine 56 novel histone deacetylase 56 Inc. Nasdaq IMGN 56 Presents Positive 56 Silodosin 56 oral rivaroxaban 56 Initiates Enrollment 56 TIDES Oligonucleotide 56 Inhalation Solution 56 J Am Soc 56 ECNP Congress 56 NACDA Convention 56 PI3K/Akt pathway inhibitor 56 Phase #/#a 56 JPMorgan SMid Cap 56 Multiple Myeloma MM 56 GLOBE NEWSWIRE Pressure BioSciences 56 Telbivudine 56 Luxe Sunset Bel Air 56 immunomodulatory agents 56 ZFP Therapeutic 56 BR.# 56 First Patient Enrolled 56 Neuropathic Pain 56 rd Annual 56 prospective multicentre 56 phase IIa 56 Delcath Phase III 56 Nasdaq DVAX 56 Lehman Brothers T4 56 SU# [003] 56 Stent Thrombosis 56 Therapeutic Radiation Oncology 56 polycythemia vera PV 56 Janus Kinase 56 Gastroenterology Week UEGW 56 Sybase TechWave 56 LD MICRO Conference 56 ASLA Annual Meeting 56 ASCRS 56 Advanced Renal Cell 56 IPAA OGIS Small Cap 56 CR# vcMMAE 56 mGluR5 negative 56 Movement Disorder 56 including eniluracil ADH 56 Amrubicin 56 Cancer Immunotherapy 56 Phase IIB 56 PKC# 56 brivaracetam 56 Crit Rev 56 PEGylated interferon beta 1a 56 randomized discontinuation trial 56 Abstract Accepted 56 orally administered inhibitor 56 Arthritis Rheum 56 CombAT 56 Aquatica SeaWorld waterpark 56 #:#-# [006] 56 Genasense ® oblimersen 56 R lenalidomide 56 MobileFocus 56 AACR 56 TORISEL TM 56 Molecular Cancer 56 XL# XL# XL# 56 PROLARIS 56 bazedoxifene conjugated estrogens 56 RGB # 56 ASGCT 56 AA Amyloidosis 56 GW# [003] 56 Clinical Microbiology 56 AAAS Fellows Forum 56 thalidomide Thalomid 56 PROactive study 56 recurrent glioblastoma multiforme 56 Menopause Society NAMS 56 TACI Ig 56 CLSA AsiaUSA Forum 56 Alternext ALEHT 56 E CENP E 56 aurora kinase 56 journal Oncogene 56 Lung Cancer IASLC 56 recurrent GBM 56 Thromb Haemost 56 Diabetic Macular Edema DME 56 riociguat 56 Exhibitor Profiles 56 neratinib 56 oral prodrug 56 kidney urologic 56 prostate cancer HRPC 56 Free Full Text 56 SIR Spheres 56 ISTH 56 Phase 2a Trial 56 Cardiology ACC 56 NASDAQ CXSP announced 56 Surgery ASLMS 56 Pivotal Clinical Trial 56 PSN# [002] 56 trial evaluating PRX# 56 multi kinase inhibitor 56 MASCC 56 BiOS 56 PRNewswire FirstCall Genaera 56 Camptosar ® irinotecan 56 IRX 2 56 Pemetrexed 56 Neulasta R 56 vidofludimus 56 forodesine 56 Memgen 56 Respiratory Society 56 pharmacokinetic PK 56 Phase III Clinical Trial 56 PRNewswire FirstCall Tercica 56 Antibody Engineering 56 EMBLEM TM 56 Pharmacoeconomics 56 seliciclib CYC# 56 FIP Pharmaceutical 56 dual endothelin receptor antagonist 56 Degarelix 56 N Engl J 56 Developmental Therapeutics Immunotherapy 56 compound AEZS 55 Microanalysis 55 ALA Midwinter Meeting 55 Bazedoxifene 55 MERIT ES 55 SYNTAX trial 55 AMEX RGN 55 In3 EUROPE 55 Addex Pharmaceuticals SWISS ADXN 55 ZD# [001] 55 Optical Fiber Communications 55 metastatic CRC 55 MGd 55 Romiplostim 55 NCVH 55 pomalidomide 55 Hyatt Regency Embarcadero 55 MEK inhibitor 55 Genta Incorporated OTCBB GETA 55 ASN Renal Week 55 rALLy trial 55 Phase III psoriasis 55 Heart Assn 55 HIMSS Annual 55 VoiceCon Fall 55 Eur J Neurol 55 Clinical Virology 55 IAAPA Attractions Expo 55 rivaroxaban Xarelto 55 PrevOnco 55 Phase 2a Clinical Trial 55 ROCKET AF 55 2 methoxyestradiol 55 Adefovir 55 FTF Americas 55 Surgical Mesh 55 worsening thrombocytopenia 55 MAGE A3 ASCI 55 Phase III Trial 55 YONDELIS R 55 DIA Annual Meeting 55 IPC APEX Expo 55 Outpatient Setting 55 Announces Poster Presentations 55 LymphoStat B 55 genitourinary cancers 55 #th Annual Retrovirus 55 Plastic Surgeons ASPS Plastic 55 iSBTc 55 ON #.Na 55 La Jolla Torrey Pines 55 Inc. NASDAQ HEPH 55 OXi# 55 elotuzumab 55 plus Copegus R 55 metaglidasen 55 CARE HF 55 Denufosol 55 sulodexide 55 BioCentury Future Leaders 55 QLT# 55 #:# -# [003] 55 Craig Hallum Institutional Investor 55 thetreatment 55 galiximab 55 Epratuzumab 55 hyaluronidase enzyme 55 placebo controlled clinical 55 AACC Annual Meeting 55 Phase III randomized controlled 55 Two Upcoming Investor 55 Schizophrenia Bulletin 55 Medicine SIIM 55 Diabetes EASD 55 Xelox 55 Daclizumab 55 Gastrointestinal Oncology 55 Gemzar ® 55 CHAMPION PCI 55 Xcytrin R 55 Panzem R 55 Refractive Surgery ASCRS 55 vivo preclinical 55 Vaccine Adjuvant 55 IBM Lotusphere 55 Prepaid Card Expo 55 orally inhaled migraine 55 PSMA ADC 55 Minimally Invasive Spine Surgery 55 #:# -# [006] 55 ATVB 55 oral ridaforolimus 55 HIV Pathogenesis 55 Enzastaurin 55 Cancer Res 55 Conference Pictometry FutureView 55 COPIC Energy 55 investigational hepatitis C 55 CUSTOM III 55 Chronic Lymphocytic Leukemia CLL 55 chromium supplementation 55 HIF PHI 55 MOZOBIL 55 mCRC patients 55 AVADO 55 STAREAST 55 BiTE antibody MT# 55 #:#-# [035] 55 SMTAI 55 Oral Session 55 Clinical Efficacy 55 Phase 2b RESTORE CLI 55 PF # [002] 55 OneMedPlace Finance Forum 55 Phase IIb clinical trials 55 Interventional Therapies 55 cloudmatt 55 PROTECT II 55 abnormal p# 55 Group RTOG 55 Prospective Randomized 55 metastatic renal cell 55 Endovascular Valve Edge 55 Kahalalide F 55 IMiD 55 TMC# C# 55 www.aacr.org 55 Investor Luncheon 55 trastuzumab DM1 55 Novel Oral 55 Mineral Research ASBMR 55 Dacogen injection 55 Philadelphia Chromosome Positive 55 ICON7 55 Anticancer Drug 55 J Nutr 55 Interventional Oncology 55 Parathyroid Hormone 55 Pharmacodynamic 55 ASH Abstract # 55 Guanilib 55 cediranib 55 taxane resistant 55 Retina Specialists ASRS 55 phase IIb 55 Myelodysplastic Syndromes 55 candesartan cilexetil 55 trabectedin 55 LSE ASM 55 randomized Phase III 55 adecatumumab MT# 55 NAREIT REITWeek 55 RNAi Therapeutic 55 CTI Nasdaq 55 LabAutomation# 55 Fulvestrant 55 Beneficial Effects 55 Pertuzumab 55 Lung Transplantation 55 RE LY 55 Windhover Therapeutic Area 55 System Pharmacists ASHP 55 Quinamed 55 ASA CSSA SSSA 55 NASDAQ LIPD 55 Placebo Controlled Trial 55 Castration Resistant Prostate Cancer 55 Diabetic Foot 55 chemotherapy gemcitabine 55 Annamycin 55 Novel Inhibitor 55 Endourology 55 RECIST Response Evaluation Criteria 55 Urocortin 2 55 Safety Tolerability 55 XL# SAR# 55 RCW Breast Cancer 55 davunetide intranasal AL 55 AACR NCI EORTC Molecular 55 ularitide 55 Luxe Sunset Boulevard 55 CNS Disorders 55 Endoscopic Surgeons SAGES 55 Randomized Study 55 Neuromodulation Society 55 OAUG Connection Point 55 ENESTnd 55 APOPTONE 55 Medtech Insight Investment 55 Annual Meeting 55 Cardiovascular Anesthesiologists 55 Polymerase Inhibitor 55 Clinical Oncology 55 phase IIIb 55 PROSTVAC VF 55 Antimicrobial Chemotherapy 55 AACR Symposium 55 receptor tyrosine kinase inhibitor 55 Patients Treated With 55 Pharmacokinetic parameters 55 sorafenib Nexavar 55 www.pranabio.com 55 TLR antagonists